vs
LAKELAND FINANCIAL CORP（LKFN）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是LAKELAND FINANCIAL CORP的1.0倍（$69.8M vs $69.7M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 38.0%，领先346.1%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 0.7%）
总部位于美国佛罗里达州坦帕的非银行消费金融服务提供商，由伊恩·麦基奇尼于1989年创立，业务网络仅覆盖佛罗里达州，核心服务涵盖支票兑现、账单支付、预付费卡、发薪日贷款、免费汇票、网点ATM服务、电汇、公证、传真及邮政服务，目前运营近240家线下零售网点。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
LKFN vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.0倍
$69.7M
净利率更高
RIGL
高出346.1%
38.0%
两年增速更快
RIGL
近两年复合增速
0.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $69.7M | $69.8M |
| 净利润 | $26.5M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 38.0% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | 31.8% | 1769.2% |
| 每股收益（稀释后） | $1.04 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LKFNRIGL
| Q1 26 | $69.7M | — | ||
| Q4 25 | $69.8M | $69.8M | ||
| Q3 25 | $69.0M | $69.5M | ||
| Q2 25 | $66.4M | $101.7M | ||
| Q1 25 | $63.8M | $53.3M | ||
| Q4 24 | $63.6M | $57.6M | ||
| Q3 24 | $61.2M | $55.3M | ||
| Q2 24 | $68.7M | $36.8M |
净利润LKFNRIGL
| Q1 26 | $26.5M | — | ||
| Q4 25 | $29.9M | $268.1M | ||
| Q3 25 | $26.4M | $27.9M | ||
| Q2 25 | $27.0M | $59.6M | ||
| Q1 25 | $20.1M | $11.4M | ||
| Q4 24 | $24.2M | $14.3M | ||
| Q3 24 | $23.3M | $12.4M | ||
| Q2 24 | $22.5M | $-1.0M |
毛利率LKFNRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率LKFNRIGL
| Q1 26 | — | — | ||
| Q4 25 | 52.1% | 33.2% | ||
| Q3 25 | 46.4% | 40.9% | ||
| Q2 25 | 49.6% | 60.1% | ||
| Q1 25 | 38.0% | 23.9% | ||
| Q4 24 | 46.0% | 28.9% | ||
| Q3 24 | 45.3% | 25.4% | ||
| Q2 24 | 39.2% | 1.2% |
净利率LKFNRIGL
| Q1 26 | 38.0% | — | ||
| Q4 25 | 42.8% | 384.0% | ||
| Q3 25 | 38.3% | 40.2% | ||
| Q2 25 | 40.6% | 58.6% | ||
| Q1 25 | 31.5% | 21.5% | ||
| Q4 24 | 38.1% | 24.9% | ||
| Q3 24 | 38.1% | 22.5% | ||
| Q2 24 | 32.8% | -2.8% |
每股收益（稀释后）LKFNRIGL
| Q1 26 | $1.04 | — | ||
| Q4 25 | $1.16 | $14.11 | ||
| Q3 25 | $1.03 | $1.46 | ||
| Q2 25 | $1.04 | $3.28 | ||
| Q1 25 | $0.78 | $0.63 | ||
| Q4 24 | $0.94 | $0.82 | ||
| Q3 24 | $0.91 | $0.70 | ||
| Q2 24 | $0.87 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $85.6M | $155.0M |
| 总债务越低越好 | $183.6M | $52.5M |
| 股东权益账面价值 | $749.0M | $391.5M |
| 总资产 | $7.1B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.25× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资LKFNRIGL
| Q1 26 | $85.6M | — | ||
| Q4 25 | $141.3M | $155.0M | ||
| Q3 25 | $192.8M | $137.1M | ||
| Q2 25 | $310.2M | $108.4M | ||
| Q1 25 | $235.2M | $77.1M | ||
| Q4 24 | $168.2M | $77.3M | ||
| Q3 24 | $160.2M | $61.1M | ||
| Q2 24 | $121.2M | $49.1M |
总债务LKFNRIGL
| Q1 26 | $183.6M | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | $30.0M | $60.0M | ||
| Q2 24 | $55.0M | $60.0M |
股东权益LKFNRIGL
| Q1 26 | $749.0M | — | ||
| Q4 25 | $762.4M | $391.5M | ||
| Q3 25 | $747.4M | $117.6M | ||
| Q2 25 | $709.9M | $81.9M | ||
| Q1 25 | $694.4M | $18.6M | ||
| Q4 24 | $683.8M | $3.3M | ||
| Q3 24 | $699.1M | $-14.6M | ||
| Q2 24 | $654.5M | $-29.9M |
总资产LKFNRIGL
| Q1 26 | $7.1B | — | ||
| Q4 25 | $7.0B | $513.6M | ||
| Q3 25 | $6.9B | $242.5M | ||
| Q2 25 | $7.0B | $206.7M | ||
| Q1 25 | $6.9B | $176.0M | ||
| Q4 24 | $6.7B | $164.0M | ||
| Q3 24 | $6.6B | $139.4M | ||
| Q2 24 | $6.6B | $128.4M |
负债/权益比LKFNRIGL
| Q1 26 | 0.25× | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.08× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流LKFNRIGL
| Q1 26 | — | — | ||
| Q4 25 | $114.9M | $22.0M | ||
| Q3 25 | $36.1M | $24.0M | ||
| Q2 25 | $16.2M | $30.5M | ||
| Q1 25 | $28.9M | $-893.0K | ||
| Q4 24 | $102.5M | $14.5M | ||
| Q3 24 | $18.0M | $21.7M | ||
| Q2 24 | $21.0M | $302.0K |
自由现金流LKFNRIGL
| Q1 26 | — | — | ||
| Q4 25 | $103.8M | — | ||
| Q3 25 | $31.1M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $27.1M | — | ||
| Q4 24 | $93.9M | — | ||
| Q3 24 | $15.3M | — | ||
| Q2 24 | $18.6M | — |
自由现金流率LKFNRIGL
| Q1 26 | — | — | ||
| Q4 25 | 148.7% | — | ||
| Q3 25 | 45.0% | — | ||
| Q2 25 | 21.2% | — | ||
| Q1 25 | 42.5% | — | ||
| Q4 24 | 147.6% | — | ||
| Q3 24 | 25.0% | — | ||
| Q2 24 | 27.0% | — |
资本支出强度LKFNRIGL
| Q1 26 | — | — | ||
| Q4 25 | 15.9% | — | ||
| Q3 25 | 7.3% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 4.4% | — | ||
| Q2 24 | 3.5% | — |
现金转化率LKFNRIGL
| Q1 26 | — | — | ||
| Q4 25 | 3.84× | 0.08× | ||
| Q3 25 | 1.37× | 0.86× | ||
| Q2 25 | 0.60× | 0.51× | ||
| Q1 25 | 1.44× | -0.08× | ||
| Q4 24 | 4.24× | 1.01× | ||
| Q3 24 | 0.77× | 1.75× | ||
| Q2 24 | 0.93× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LKFN
| Net Interest Income | $56.8M | 81% |
| Noninterest Income | $12.9M | 19% |
RIGL
暂无分部数据
